Type of medicine: Non-centrally authorised vaccines
|
Therapeutic area: Virus Diseases
|
Brands: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
ATC code: |
Document link:
|
Document date: 2011-11-22
|
Study number: 209762/138 (MeMuRu-138) |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
Y
|
-
|
-
|